早产亚型与早产儿视网膜病变的关系
一项在科罗拉多州单中心开展的回顾性队列研究纳入827例接受早产儿视网膜病变筛查的婴儿,比较自发性早产、医学指征早产与未足月胎膜早破三种亚型1型或2型早产儿视网膜病变的发生率。校正胎龄、出生体重和经产后,自发性早产和医学指征早产相对于未足月胎膜早破的比值比分别为6.1和5.5。未足月胎膜早破组中破膜持续时间≤24小时者发生1型或2型早产儿视网膜病变的比值比为9.0。
要点
- 自发性早产、医学指征早产、未足月胎膜早破的1型或2型早产儿视网膜病变发生率分别为17%、10%和6%。
- 校正胎龄、出生体重和经产后,自发性早产与医学指征早产相对于未足月胎膜早破的比值比分别为6.1和5.5。
- 未足月胎膜早破者中破膜≤24小时相对于>24小时的比值比为9.0。
核心结论
- 1型或2型早产儿视网膜病变是与较低胎龄和出生体重以及触发早产的宫内环境事件相关的眼部不良结局。
- 未足月胎膜早破组1型或2型早产儿视网膜病变发生率低于其他早产原因,可能与未足月胎膜早破相关的围产期治疗(如糖皮质激素、抗生素、母胎监测)对早产儿视网膜病变的发生有抑制作用有关。
- 作者建议,使婴儿易患1型或2型早产儿视网膜病变的生理事件在分娩前即已开始。
研究设计与样本
- 回顾性队列研究,纳入在科罗拉多州单一三级医疗中心分娩并接受早产儿视网膜病变筛查的827例婴儿。
- 所有婴儿均符合美国儿科学会2013年早产儿视网膜病变筛查标准:出生体重≤1500 g或胎龄≤30周(由主治新生儿科医生判定),以及部分出生体重1500–2000 g或胎龄>30周但临床过程不稳定(包括需要心肺支持)且被主治儿科医生或新生儿科医生认为早产儿视网膜病变高风险的婴儿。
- 由两名对早产儿视网膜病变结局设盲的独立评审者判定早产是否由自发性早产、医学指征早产或未足月胎膜早破所致,分歧由第三名评审者解决。
- 数据分析采用单因素和多因素逻辑回归。
主要发现
- 队列中自发性早产、医学指征早产和未足月胎膜早破的频率分别为34%、40%和26%。
- 整个队列平均胎龄(周,天)±标准差(范围)为28周6天±2周3天(23周3天至36周4天);自发性早产为28周1天±2周3天(23周3天至33周4天);医学指征早产为29周1天±2周2天(24周至36周4天);未足月胎膜早破为28周4天±2周1天(24周至33周1天)。
- 在1型、2型或无早产儿视网膜病变的婴儿中,自发性早产、医学指征早产和未足月胎膜早破所致分娩的1型或2型早产儿视网膜病变发生率分别为218例中37例(17%)、272例中27例(10%)和164例中10例(6%)。
- 校正胎龄、出生体重和经产后,与未足月胎膜早破组相比,自发性早产和医学指征早产发生1型或2型早产儿视网膜病变的比值比分别为6.1(95%置信区间1.8至20,P=0.003)和5.5(95%置信区间1.4至21,P=0.01)。
- 未足月胎膜早破后分娩的新生儿中,破膜持续时间至多24小时者发生1型或2型早产儿视网膜病变的概率最大,超过24小时后概率下降;破膜≤24小时者相对于破膜>24小时者发生1型或2型早产儿视网膜病变的比值比为9.0(95%置信区间2.3至34,P=0.002)。
关键数值与推荐
- 美国儿科学会2013年早产儿视网膜病变筛查标准:出生体重≤1500 g或胎龄≤30周(由主治新生儿科医生判定),以及部分出生体重1500–2000 g或胎龄>30周但临床过程不稳定(包括需要心肺支持)且被主治儿科医生或新生儿科医生认为早产儿视网膜病变高风险的婴儿。
临床怎么用
- 作者建议,使婴儿易患1型或2型早产儿视网膜病变的生理事件在分娩前即已开始。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Retinopathy of prematurity is an adverse outcome of preterm birth and is a leading cause of childhood blindness. The relationship between the subtypes of preterm birth with retinopathy of prematurity is understudied. OBJECTIVE: To investigate whether there is a difference in the incidence of type 1 or type 2 retinopathy of prematurity in infants with preterm birth resulting from spontaneous preterm labor, a medical indication of preterm birth, or preterm premature rupture of the membranes. STUDY DESIGN: A retrospective cohort study was conducted of 827 infants screened for retinopathy of prematurity who were delivered at a single tertiary care center in Colorado. All infants fulfilled the American Academy of Pediatrics 2013 screening criteria for retinopathy of prematurity defined as "infants with a birth weight of ≤1500 g or gestational age of 30 weeks or less (as defined by the attending neonatologist) and selected infants with a birth weight between 1500 and 2000 g or gestational age of >30 weeks with an unstable clinical course, including those requiring cardiorespiratory support and who are believed by their attending pediatrician or neonatologist to be at high risk for retinopathy of prematurity." Two independent reviewers masked to retinopathy of prematurity outcomes determined whether preterm birth resulted from spontaneous preterm labor, medical indication of preterm birth, or preterm premature rupture of the membranes. Discrepancies were resolved by a third reviewer. Data were analyzed with univariate and multivariable logistic regression. RESULTS: In our cohort, the frequency of preterm birth resulting from spontaneous preterm labor, medical indication of preterm birth, or preterm premature rupture of the membranes was 34%, 40%, and 26%, respectively. The mean gestational age (weeks, days) ± SD (range) in the cohort and across the preterm birth subtypes was as follows: entire cohort, 28 weeks, 6 days ± 2 weeks, 3 days (23 weeks, 3 days - 36 weeks, 4 days); spontaneous preterm labor, 28 weeks 1 day ± 2 weeks, 3 days (23 weeks, 3 days - 33 weeks, 4 days); medical indication of preterm birth, 29 weeks, 1 day ± 2 weeks, 2 days (24-36 weeks, 4 days); preterm premature rupture of the membranes, 28 weeks, 4 days ± 2 weeks, 1 day (24-33 weeks, 1 day). Among infants with type 1, type 2, or no retinopathy of prematurity, the incidence of type 1 or type 2 retinopathy of prematurity in births from spontaneous preterm labor, medical indication of preterm birth, and preterm premature rupture of the membranes was 37 of 218 (17%), 27 of 272 (10%), and 10 of 164 (6%), respectively. Adjusted for gestational age, birth weight, and multiparity and compared with the preterm premature rupture of the membranes group, the odds ratios of spontaneous preterm labor and medical indication of preterm birth for type 1 or type 2 retinopathy of prematurity were 6.1 (95% confidence interval, 1.8 to 20, P = .003) and 5.5 (95% confidence interval, 1.4 to 21, P = .01), respectively. Among neonates born after preterm premature rupture of the membranes, the probability of developing type 1 or type 2 retinopathy of prematurity was greatest in infants with rupture of membrane duration of up to 24 hours. After 24 hours, the probability of developing type 1 or type 2 retinopathy of prematurity declined. The odds of developing type 1 or type 2 retinopathy of prematurity was 9.0 (95% confidence interval 2.3 to 34, P = .002) in infants who had preterm premature rupture of the membranes ≤ 24 hours compared with infants who had preterm premature rupture of the membranes > 24 hours. CONCLUSION: Type 1 or type 2 retinopathy of prematurity are adverse ocular outcomes linked with not only lower gestational age and birth weight at delivery but also with events in the intrauterine environment that trigger a preterm birth. The reduced incidence of type 1 or type 2 retinopathy of prematurity in the preterm premature rupture of the membranes group compared with other causes of preterm birth may be related to the perinatal therapies associated with preterm premature rupture of the membranes (such as corticosteroids, antibiotics, maternal-fetal surveillance), which may have an inhibitory effect on the development of retinopathy of prematurity. We suggest that the physiologic events that predispose infants to type 1 or type 2 retinopathy of prematurity begin before delivery.
引用
- Lynch AM, Wagner BD, Hodges JK, et al. The relationship of the subtypes of preterm birth with retinopathy of prematurity. Am J Obstet Gynecol. 2017. PMID: 28545834. doi:10.1016/j.ajog.2017.05.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。